Remove tag long-term-plan
article thumbnail

Grand Rounds June 16, 2023: BeatPain Utah: Partnering With Community Health Centers Within a Socio-Technical Framework (Julie Fritz, PT, PhD, FAPTA; Guilherme Del Fiol, MD, PhD)

Rethinking Clinical Trials

Clinical research can exacerbate disparities, because clinical trials typically are based in urban, academic medical centers, underrepresent diverse populations, and overlook community engagement strategies in trial planning and design.

article thumbnail

Lyfgenia and Casgevy Become First FDA-Approved Gene Therapies for Sickle Cell Disease

XTalks

Morgan analysts were also hopeful about bluebird’s clearer commercialization plan for Lyfgenia and market readiness from Zynteglo. Data on the long-term effects of the therapies is limited, as trials evaluating the therapies were only two years long. Vertex-CRISPR’s Casgevy has a US list price of $2.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds August 12, 2022: Equitably Including Diverse Participants in Pragmatic Clinical Trials (Consuelo H. Wilkins, MD, MSCI)

Rethinking Clinical Trials

These terms and designations were intended to restrict rights. The recruitment plan needs to include study materials that are tailored and accessible to the research population. We have a long way to go; we are talking about data we don’t currently collect. How we categorize race and ethnicity in the U.S. Who is asking?

article thumbnail

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

The Pharma Data

Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. CHENGDU, China , Feb.

article thumbnail

No sign of stopping: The rise of cell and gene therapy

Drug Discovery World

But are these price tags a barrier to access? In the case of Hemgenix, the assurance behind the price point is that the drug would reduce long-term healthcare costs as patients would have fewer healthcare incidents and need fewer clotting treatments. million per dose.

article thumbnail

A history of Pfizer

pharmaphorum

Few companies embody the term ‘pharma giant’ as much as Pfizer. The deal seemed to be a precursor to Pfizer’s plans to separate its patent-protected medicines business from its off-patent portfolio. The Board is firm in its conviction as to the appropriate terms to recommend to shareholders.”.

Sales 127
article thumbnail

Ways IoT Has Transformed The Pulse Of Healthcare, And Will Continue To Do So In The Future

Delveinsight

Since the data is collected for a long period of time, the doctor can easily evaluate the current and past medical conditions. Since the data is collected over a very long period, it can bring new insight and information which will help understand the functioning of the body and also ensures better medical treatments and productivity.

Doctors 59